1. Home
  2. dsm-firmenich

Tag: dsm-firmenich

Ingredients
India approves dsm-firmenich’s 2′-FL HMO

India approves dsm-firmenich’s 2′-FL HMO

This regulatory milestone marks a new opportunity to enhance infant health, as well as support HMO innovation in the region dsm-firmenich, a global innovator in health, nutrition and beauty, has today announced the approval of

People
dsm-firmenich appoints Laetitia Pictet Chief Legal, Risk and Compliance Officer

dsm-firmenich appoints Laetitia Pictet Chief Legal, Risk and Compliance Officer

Laetitia will join the company’s Executive Committee, reporting directly to CEO Dimitri de Vreeze dsm-firmenich, innovators in nutrition, health, and beauty, announced the appointment of Laetitia Pictet as Chief Legal, Risk and Compliance Officer (CLRCO),

Ingredients
dsm-firmenich launches Maxiren EVO coagulant enzyme

dsm-firmenich launches Maxiren EVO coagulant enzyme

Maxiren EVO helps cheesemakers tackle these modern-day hurdles with one solution dsm-firmenich, an innovator in nutrition, health, and beauty, introduces Maxiren EVO, the latest breakthrough in coagulant enzymes designed to transform cheese production. Maxiren EVO

Ingredients
Vivici secures €32.5Mn in series A funding

Vivici secures €32.5Mn in series A funding

The funding round was led by APG on behalf of ABP, one of the largest pension funds in the world, and Invest-NL Vivici, the Dutch ingredients startup backed by nutrition, health and beauty multinational dsm-firmenich

Nutritionals
dsm-firmenich completes sale of MEG-3 fish oil business to KD Pharma

dsm-firmenich completes sale of MEG-3 fish oil business to KD Pharma

The production facilities in Piura, Peru, and Mulgrave, Canada are also part of this transfer dsm-firmenich, a leader in nutrition, health, and beauty, has completed the sale and transfer of its MEG-3 fish oil business

Nutritionals
dsm-firmenich to sell MEG-3 fish oil business to KD Pharma Group

dsm-firmenich to sell MEG-3 fish oil business to KD Pharma Group

The transaction includes dsm-firmenich's MEG-3 business for the Food & Beverage, Dietary Supplement and Pharma markets, together with the production facilities in Piura, Peru and Mulgrave, Canada dsm-firmenich, an innovator in nutrition, health, and beauty, today announces the sale

World
Lesaffre acquires dsm-firmenich’s yeast extract business

Lesaffre acquires dsm-firmenich’s yeast extract business

This acquisition of talent and know-how and a technology partnership with dsm-firmenich will strengthen Lesaffre's trajectory in the savoury ingredients market Lesaffre, an independent key global player in fermentation and microorganisms, announces the signing of

World
dsm-firmenich marks milestone in ampli-D® authorisation with EU approval

dsm-firmenich marks milestone in ampli-D® authorisation with EU approval

Available as a market-ready solution, ampli-D® can help nutraceutical brands fast-track innovation pipelines and quickly bring meaningful products targeting key health areas to market dsm-firmenich, an innovator in nutrition, health, and beauty, has announced the

World
Lallemand Health and dsm-firmenich partners for early-life synbiotic solutions

Lallemand Health and dsm-firmenich partners for early-life synbiotic solutions

Together they are introducing four science-based synbiotic concepts to support infant health Lallemand Health Solutions and dsm-firmenich are joining forces to launch early-life synbiotic solutions, leveraging the synergy of probiotics and human milk oligosaccharides (HMOs).

Ingredients
dsm-firmenich and Deloitte partner for animal protein value chain

dsm-firmenich and Deloitte partner for animal protein value chain

Joint initiatives will help to connect players throughout the value chain on sustainability data and reporting, facilitate dialogue and understanding with key opinion leaders, bridge knowledge gaps and foster a deeper understanding of the challenges